{{Rsnum
|rsid=1139916
|Gene=GABRE
|Chromosome=X
|position=151969707
|Orientation=minus
|GMAF=0.312
|Gene_s=GABRE
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 54.9 | 19.5 | 25.7
| HCB | 83.2 | 11.7 | 5.1
| JPT | 81.4 | 8.0 | 10.6
| YRI | 29.3 | 23.8 | 46.9
| ASW | 22.8 | 38.6 | 38.6
| CHB | 83.2 | 11.7 | 5.1
| CHD | 86.1 | 9.3 | 4.6
| GIH | 77.2 | 16.8 | 5.9
| LWK | 36.4 | 26.4 | 37.3
| MEX | 72.4 | 17.2 | 10.3
| MKK | 37.8 | 25.6 | 36.5
| TSI | 59.8 | 15.7 | 24.5
| HapMapRevision=28
}}{{PMID Auto
|PMID=21422964
|Title=Gamma-aminobutyric acid GABRA4, GABRE, and GABRQ receptor polymorphisms and risk for essential tremor
}}

{{GET Evidence
|gene=GABRE
|aa_change=Ser102Ala
|aa_change_short=S102A
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1139916
|overall_frequency_n=5357
|overall_frequency_d=8761
|overall_frequency=0.61146
|n_genomes=38
|n_genomes_annotated=0
|n_haplomes=71
|n_articles=0
|n_articles_annotated=0
|pph2_score=0.902
|nblosum100=-1
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}